FemmePharma Global Healthcare

FemmePharma develops over-the-counter treatment products for diseases and disorders that disproportionately affect women.

FemmePharma develops prescription treatment options for diseases and disorders that disproportionately affect women.

The company focuses on innovation and science and develops products intended to improve women's health around the world.

FemmePharma Global Healthcare, Inc. announced that Gerianne Tringali DiPiano would participate in a panel discussion on exits, traps, and triumphs, co-hosted by the Drexel University LeBow College of Business and the Close School of Entrepreneurship in Philadelphia.

FemmePharma Global Healthcare, Inc. announced that Gerianne Tringali DiPiano would participate in a panel discussion on legal responses to the opioid addiction crisis at the University of Pennsylvania Center for Ethics and the Rule of Law on March 16, 2018.

The page provides health news and information about conditions and issues that disproportionately affect women and FemmePharma’s efforts to address them.

Gerianne Tringali DiPiano is President and Chief Executive Officer of FemmePharma and Chairman of its Board of Directors.

FemmePharma Global Healthcare, Inc., a pharmaceutical company, engages in developing drugs for diseases and disorders affecting women internationally.

FemmePharma manufactures FDA-approved products for women.

FemmePharma is devoted to developing over-the-counter and prescription treatment options to address diseases and disorders that disproportionately affect women.

This Privacy Policy applies only to the websites controlled by FemmePharma Holding Companies its affiliates and subsidiaries (collectively, the “Company”) where this privacy policy is posted or referenced (collectively, the “Sites”).